Generation Bio Co Stock Market Value
| GBIO Stock | USD 0.81 0.05 5.81% |
| Symbol | Generation |
Generation Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.19) | Revenue Per Share | Quarterly Revenue Growth 2.52 | Return On Assets | Return On Equity |
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Generation Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Generation Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Generation Bio.
| 01/01/2025 |
| 01/31/2025 |
If you would invest 0.00 in Generation Bio on January 1, 2025 and sell it all today you would earn a total of 0.00 from holding Generation Bio Co or generate 0.0% return on investment in Generation Bio over 30 days. Generation Bio is related to or competes with Monte Rosa, Nkarta, Lyell Immunopharma, Sana Biotechnology, Kronos Bio, Erasca, and C4 Therapeutics. Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases More
Generation Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Generation Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Generation Bio Co upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.31) | |||
| Maximum Drawdown | 22.69 | |||
| Value At Risk | (8.33) | |||
| Potential Upside | 6.74 |
Generation Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Generation Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Generation Bio's standard deviation. In reality, there are many statistical measures that can use Generation Bio historical prices to predict the future Generation Bio's volatility.| Risk Adjusted Performance | (0.23) | |||
| Jensen Alpha | (1.44) | |||
| Total Risk Alpha | (1.89) | |||
| Treynor Ratio | (2.09) |
Generation Bio Backtested Returns
Generation Bio holds Efficiency (Sharpe) Ratio of -0.32, which attests that the entity had a -0.32 % return per unit of risk over the last 3 months. Generation Bio exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Generation Bio's Risk Adjusted Performance of (0.23), market risk adjusted performance of (2.08), and Standard Deviation of 4.79 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.66, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Generation Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Generation Bio is expected to be smaller as well. At this point, Generation Bio has a negative expected return of -1.54%. Please make sure to check out Generation Bio's maximum drawdown, as well as the relationship between the accumulation distribution and day typical price , to decide if Generation Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.60 |
Good predictability
Generation Bio Co has good predictability. Overlapping area represents the amount of predictability between Generation Bio time series from 1st of January 2025 to 16th of January 2025 and 16th of January 2025 to 31st of January 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Generation Bio price movement. The serial correlation of 0.6 indicates that roughly 60.0% of current Generation Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.6 | |
| Spearman Rank Test | 0.35 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Generation Bio lagged returns against current returns
Autocorrelation, which is Generation Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Generation Bio's stock expected returns. We can calculate the autocorrelation of Generation Bio returns to help us make a trade decision. For example, suppose you find that Generation Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Generation Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Generation Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Generation Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Generation Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Generation Bio Lagged Returns
When evaluating Generation Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Generation Bio stock have on its future price. Generation Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Generation Bio autocorrelation shows the relationship between Generation Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Generation Bio Co.
Regressed Prices |
| Timeline |
Pair Trading with Generation Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Generation Stock
Moving against Generation Stock
| 0.62 | MLAB | Mesa Laboratories Earnings Call This Week | PairCorr |
| 0.56 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.31 | GILD | Gilead Sciences Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Generation Bio Correlation, Generation Bio Volatility and Generation Bio Alpha and Beta module to complement your research on Generation Bio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Generation Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.